Drugs / Allogenic islet cells (human, U. Chicago)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00160732 | Oct 2003 → Oct 2030 expected | type 1 diabetes mellitus | University of Chicago | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic islet cells (human, U. Chicago) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00160732 ↗ |
| Route | Other | “Administered Via Intraportal Infusion” NCT00160732 ↗ |